1. Home
  2. EVOK vs CHNR Comparison

EVOK vs CHNR Comparison

Compare EVOK & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • CHNR
  • Stock Information
  • Founded
  • EVOK 2007
  • CHNR N/A
  • Country
  • EVOK United States
  • CHNR China
  • Employees
  • EVOK N/A
  • CHNR N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • CHNR Precious Metals
  • Sector
  • EVOK Health Care
  • CHNR Basic Materials
  • Exchange
  • EVOK Nasdaq
  • CHNR Nasdaq
  • Market Cap
  • EVOK 5.4M
  • CHNR 5.3M
  • IPO Year
  • EVOK 2013
  • CHNR 1995
  • Fundamental
  • Price
  • EVOK $5.12
  • CHNR $4.81
  • Analyst Decision
  • EVOK
  • CHNR
  • Analyst Count
  • EVOK 0
  • CHNR 0
  • Target Price
  • EVOK N/A
  • CHNR N/A
  • AVG Volume (30 Days)
  • EVOK 432.5K
  • CHNR 67.8K
  • Earning Date
  • EVOK 11-06-2025
  • CHNR 11-11-2025
  • Dividend Yield
  • EVOK N/A
  • CHNR N/A
  • EPS Growth
  • EVOK N/A
  • CHNR N/A
  • EPS
  • EVOK N/A
  • CHNR N/A
  • Revenue
  • EVOK $12,794,859.00
  • CHNR N/A
  • Revenue This Year
  • EVOK $57.38
  • CHNR N/A
  • Revenue Next Year
  • EVOK $59.57
  • CHNR N/A
  • P/E Ratio
  • EVOK N/A
  • CHNR N/A
  • Revenue Growth
  • EVOK 70.02
  • CHNR N/A
  • 52 Week Low
  • EVOK $1.94
  • CHNR $3.16
  • 52 Week High
  • EVOK $12.32
  • CHNR $9.04
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 49.82
  • CHNR 60.56
  • Support Level
  • EVOK $5.00
  • CHNR $3.87
  • Resistance Level
  • EVOK $5.27
  • CHNR $5.20
  • Average True Range (ATR)
  • EVOK 0.22
  • CHNR 0.44
  • MACD
  • EVOK -0.05
  • CHNR 0.09
  • Stochastic Oscillator
  • EVOK 38.91
  • CHNR 76.07

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About CHNR China Natural Resources Inc.

China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.

Share on Social Networks: